AfternsAfterns
Up or down this time?Nov 5 scheduled
0%0%

···

PT

PTC Therapeutics Inc. (PTCT) earnings date & stock reaction

PTC Therapeutics Inc. · Healthcare

PTC Therapeutics Inc. earnings date & time

Next earningsThu, November 5 around 4:00 PM ET, after the closescheduled

Schedule

Korea time (KST)
Fri, November 6
Reporting pattern
12 of last 12 after close
Typical move
±9.8% · 12-report avg

What the market expects

Consensus EPS

$0.31Coming in above this counts as a beat

Full earnings calendarFrom an earnings calendar

Price after the latest report

Reported July 30, 2026how the stock moved around it
Next-day move
-9.9%
After 5 days
-6.2%
Price around earnings
Around this report
Overlapped an FOMC holdThis report landed on a US Federal Reserve rate-decision day. Rate decisions move the whole market, so the move may reflect the decision, not just earnings. A cut is not always good or a hike always bad. Crisis cuts fell, and hikes in a strong economy often rose.

PTC Therapeutics Inc. (PTCT) rose the day after earnings in 8 of its last 12 reports (67%), moving ±9.8% on average. It has fallen despite beating the consensus estimate 2 times.

Up next day
8/12
67%
Fell despite growth
3/12
Good earnings ignored
Price when beating
+3.6%
avg over 7 beats
Price when missing
0.0%
avg over 5 misses
Avg earnings move
±9.8%
typical swing on earnings
Biggest single move
-22.7%
'23.10 · largest reaction
🔑What actually moves this stock?
What really matters here
Key product sales and the company's outlook
In finance terms: Product sales · guidance
Growth · revenue (YoY by quarter, latest right)
+460%
25-05(Mar qtr)
-4%
25-08(Jun qtr)
+7%
25-11(Sep qtr)
-23%
26-02(Dec qtr)
-77%
26-05(Mar qtr)
+102%
26-07(Jun qtr)
Spiked (M&A/one-off?) · It jumped to +102% last quarter, but before that it was slowing (+460% → -77%). This spike may be M&A/one-off.
What to watch next report

When results drop, skip the EPS number. Check if the growth above holds or accelerates, and whether guidance beats expectations.

The real bar for this stock

Beating estimates isn't enough. Here's where the real surprise started.

Beat consensus 6 of 11 times
Median beat +93.2%. 2 of those beats still fell the next day.

How this stock reacts to earnings

Traits seen across its recent earnings reactions

Good results usually push the stock up
Up the next day 5 of 7 beats (71%)
Moves in line with results, fairly predictable
Avg +3.6% on a beat, 0.0% on a miss
Big earnings-day moves tend to fade within days
Reversed the day-one move · 67% of last 12
vs Healthcare sector avg (155 peers)
This
+2.1%
Sector
+0.5%
Avg next-day reaction

Earnings number vs guidance: which drives it?

How often the beat/miss matched the actual price move

The number and guidance move the price about equally
Moved opposite to results 5 of last 12 times (42%)
2xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Fell despite growth3/12

2/7 beats fell next day · watches Product sales · guidance

Next-day reaction
  • Jun 2026 report-9.9%
  • Mar 2026 report+14.3%
  • Dec 2025 report+1.1%
  • Sep 2025 report+6.0%
  • Jun 2025 report-9.9%
  • Mar 2025 report+12.6%

Earnings timeline · bars = next-day move, ▲▼ = beat/miss

Apr–Jun 2026 results
Reported 2026-07-30
Next-day move
-9.9%
After 5 days -6.2%
EPS consensus $0.34 → $0.92 ▲ +170.6% beatRev $179M → $361M +102% YoY
Beat by +170.6% but stock -9.9%
Price around earnings
Around this report
Overlapped an FOMC holdThis report landed on a US Federal Reserve rate-decision day. Rate decisions move the whole market, so the move may reflect the decision, not just earnings. A cut is not always good or a hike always bad. Crisis cuts fell, and hikes in a strong economy often rose.

Earnings trend · last 12 quarters

EPS$0.92YoY +211%
'23.10'26.7
Revenue$0.4BYoY +102%
'23.10'26.7

Earnings history and price reaction

PTC Therapeutics Inc. across its last 12 earnings reports: EPS versus consensus, the move on the earnings day, and the cumulative move five trading days later.
Quarter endedReported (ET)vs market expectation (consensus)Earnings dayAfter 5 days
6/20262026-07-30+170.6%†-9.9%-6.2%
3/20262026-05-07+93.2%+14.3%+12.8%
12/20252026-02-19-350.0%†+1.1%-2.6%
9/20252025-11-04+116.9%†+6.0%+9.0%
6/20252025-08-07+21.9%-9.9%-3.3%
3/20252025-05-06—+12.6%+28.2%

12 reports, quarters ending 9/2023 to 6/2026. The earnings-day move is the first trading day that reflects the report; the five-day figure is the cumulative move from that point.

Frequently asked questions

When is the next PTC Therapeutics Inc. earnings date?

The next PTC Therapeutics Inc. (PTCT) earnings report is expected Thu, November 5 around 4:00 PM ET, after the close. It comes from an earnings calendar and may not be a company-confirmed date; it updates automatically if it changes.

What is the consensus EPS forecast for PTC Therapeutics Inc.'s next earnings?

Analysts expect EPS of about $0.31 for PTC Therapeutics Inc. (PTCT). Coming in above that counts as a beat, below it a miss — though a beat does not guarantee the stock rises.

Does PTC Therapeutics Inc. (PTCT) stock usually go up after earnings?

Over the last 12 earnings reports, the stock rose on 8 of them (67%). The average move on earnings day was ±9.8%.

Does PTC Therapeutics Inc. react more to the earnings numbers or to guidance?

In 5 of the last 12 reports (42%), the stock moved the opposite way from whether it beat or missed the forecast. A high share means guidance and expectations drive the move more than the reported numbers.

Can PTC Therapeutics Inc. stock fall even when earnings are good?

Yes. In 3 of the last 12 reports, PTC Therapeutics Inc. fell on the earnings day despite growing EPS. Expectations already priced in, or guidance, can matter more than the reported numbers.

Does PTC Therapeutics Inc. stock keep moving after the earnings day?

Over the last 12 reports, the move continued in the same direction for the following five trading days 33% of the time. This tendency is known as post-earnings announcement drift.